Wexler William A. 4
4 · Comera Life Sciences Holdings, Inc. · Filed Nov 14, 2023
Insider Transaction Report
Form 4
Wexler William A.
Director
Transactions
- Award
Stock Option (Right to Purchase)
2023-11-09+75,376→ 75,376 totalExercise: $0.32From: 2023-11-09Exp: 2033-11-09→ Common Stock (75,376 underlying)
Footnotes (2)
- [F1]Granted pursuant to the Comera Life Sciences Holdings, Inc. 2022 Equity and Incentive Plan. The options were fully vested on the date of grant.
- [F2]In furtherance of the registrant's cash conservation efforts, the options were granted in lieu of the annual cash retainer and committee fees due to non-employee directors for the quarter ended September 30, 2023, in accordance with the registrant's February 2023 temporary modification to its non-employee director compensation plan. This option was issued to the reporting person in lieu of retainer fees of $10,000. For more information related to the registrant's non-employee director compensation plan and the February 2023 temporary modification, see the registrant's Annual Report on Form 10-K for the year ended December 31, 2022.